Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Clinical Chemistry Market Forecast Report 2022: A $17.1 Billion Market by 2027 - Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis -

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 11, 2023 GMT

DUBLIN--(BUSINESS WIRE)--Jan 11, 2023--

The “Clinical Chemistry Market, Size, Global Forecast 2023-2027, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to’s offering.

Globally, Clinical Chemistry Market is expected to reach US$ 17.1 Billion by 2027 from US$ 13.6 Billion in 2022, growing with a 4.69% during the forecast period 2022 - 2027

Clinical chemistry, commonly referred to as medical or clinical biochemistry, is a globally active sector that is rapidly growing. It is a branch of clinical pathology that frequently raises concerns when bodily fluids are analyzed for therapeutic and diagnostic purposes. Blood and urine are a couple of the most common body fluids analyzed in clinical chemistry.

Clinical chemistry for enzymes frequently reveals information about these things when it comes to disorders like pancreatic cancer or damage to the body’s organs. Moreover, for diagnosing cardiac and cancer problems, clinical chemistry also contains assays that serve as heart and tumour markers.


The market for clinical chemistry will be driven by the rising incidence of infectious and chronic diseases, such as cancer and diabetes, which create a need for prompt and precise diagnosis.

Furthermore, the clinical chemistry industry is also being driven by factors such as an unhealthy diet, the rising geriatric population, a sedentary lifestyle, and a lack of exercise that can result in lifestyle illnesses.

In addition, the market will continue to expand during the forecast period because of technological advancements, rising disposable incomes driving up demand for improved diagnostics, and the life-threatening nature of diseases and disorders.

By Product Type, Reagents dominate the Market:

Over the coming years, the market for clinical chemistry reagents is expected to expand as more industries use these tools to diagnose various diseases. In addition, clinical chemistry chemicals are utilized in preclinical research to track the progression of the disease and medication development.

Furthermore, reagents are beneficial for numerous scientific studies that aim to comprehend the mode of action and interactions between various product cycle stages.


COVID-19 Helped the Clinical Chemistry Industry to Grow:

The COVID-19 epidemic caused significant hurdles for the healthcare sector. But when the COVID-19 infection spread, more clinical chemistry testing for SARS-CoV-2 virus carriers was carried out. Tests including procalcitonin, albumin, lactate dehydrogenase, and the C-reactive protein (CRP), as well as less common ones like lactate dehydrogenase and procalcitonin, were used to assess organ involvement and disease severity and to estimate the probability of morbidity and mortality.

Moreover, during the pandemic, the clinical chemistry tests and the serological testing assisted in keeping track of the affected people’s general health. Therefore, the COVID-19 pandemic increased the use of these tests, which contributed significantly to the market’s expansion and had a favorable effect on that market’s growth.


Basic Metabolic Panel holds the Largest Share by Test Type:

A basic metabolic panel evaluates kidney function, fluid and electrolyte balance, and blood sugar levels through a blood test. According to WHO estimates, there are 422 million diabetics worldwide, the majority of whom reside in low- and middle-income nations.

Additionally, diabetes is directly responsible for 1.5 million deaths annually. Over the past few decades, diabetes diagnoses and prevalence have been continuously increasing. Hence, the ageing population and rise in chronic diseases, including diabetes, renal disease, and liver disease, are anticipated to fuel basic metabolic panel testing during the forecast period.

By Technology, Fully Automated will grow during the Forecast Period:

Fully Automated Clinical chemistry testing is becoming popular due to increased testing volume and quicker processing times provided by them.


Additionally, with advanced processing, automated clinical chemistry testing boosts user protection from biohazards and decreases the possibility of cross-contamination, due to which fully automated clinical chemistry testing will continue to expand during the forecast period.

The hospital segment holds the lion’s share:

Due to the rising patient load and frequent readmissions, hospitals held a substantial market share in the clinical chemistry market. Additionally, growing government initiatives to support adequate diagnostic facilities that produce speedy results and enhance overall efficiency also plays a significant role in the market expansion for this segment.

By Region, North America dominates the Market:

The presence of highly developed healthcare facilities, rising incidence of chronic disease, and increasing R&D and product developments by North America’s leading market participants are the significant drivers of market growth in the region. As updated by Centres for Disease Control and Prevention in July 2022, chronic diseases are the primary cause of mortality in the United States every year.


Furthermore, the Asia Pacific region will also expand its market share over the forecast period because of the rising healthcare expenditure, chronic disease prevalence, and technological advancement.

Key Players Analysis:

To maintain their industrial position, these companies are concentrating on expansion strategies, including mergers and acquisitions.

Leading players in the clinical chemistry market include

  • Abbott Laboratories
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Hitachi
  • HORIBA, Ltd
  • Johnson & Johnson
  • Siemens Healthineers
  • Sysmex ADR
  • Thermo Fisher Scientific

Key Topics Covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. Global Clinical Chemistry Market

6. Market Share - Clinical Chemistry Market

6.1 By Product Type

6.2 By Test Type

6.3 By Technology

6.4 By End User

6.5 By Region

7. Product Type - Clinical Chemistry Market

7.1 Reagents

7.1.1 Small (400-800 Test/H)

7.1.2 Medium (800-1200 Tests/ H)

7.1.3 Large (1200-2000 Test/ H)

7.1.4 Very Large (2000 Test/H)

7.2 Analyzers

7.2.1 Liquid

7.2.2 Solid

7.2.3 Others

7.3 Others

8. Test Type - Clinical Chemistry Market

8.1 Basic Metabolic Panel

8.2 Electrolyte Panel

8.3 Liver Panel

8.4 Lipid Profile

8.5 Renal Profile

8.6 Thyroid Function Panel

8.7 Specialty Chemical tests

9. Technology - Clinical Chemistry Market

9.1 Semi-automated Clinical Chemistry

9.2 Fully Automated Clinical Chemistry

10. End User - Clinical Chemistry Market

10.1 Hospital

10.2 Academic Research Centers

10.3 Diagnostics Laboratories

10.4 Others

11. Region - Clinical Chemistry Market

11.1 North America

11.2 Europe

11.3 Asia Pacific

11.4 Middle East & Africa

11.5 Latin America

12. Key Players

12.1 Overview

12.2 Recent Development

12.3 Revenue

For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2023.

PUB: 01/11/2023 08:24 AM/DISC: 01/11/2023 08:24 AM